Inventor · disambiguated record
Hiroaki Mitsuya
Also filed as: MITSUYA HIROAKI
38 granted patents·8 pending applications·664 citations·filing 1985–2022
97Inventor score
Files withPURDUE RESEARCH FOUNDATION17US HEALTH13YAMASA CORP5GHOSH ARUN K4NAT CENTER FOR GLOBAL HEALTH AND MEDICINE2
Top patents by PatentIndex Score
46 records- 0196US5026687ATreatment of human retroviral infections with 2',3'-dideoxyinosine alone and in combination with other antiviral compoundsUS HEALTH·Filed 1990·Granted Jun 25, 1991·200 cites·27 claims
- 0296US4861759AAntiviral compositions and methodsUS HEALTH·Filed 1987·Granted Aug 29, 1989·116 cites·22 claims
- 0391US7339053B24′-C-substituted-2-haloadenosine derivativeYAMASA CORP·Filed 2005·Granted Mar 4, 2008·40 cites·10 claims
- 0488US7625877B24′-c-substituted-2-haloadenosine derivativeYAMASA CORP·Filed 2007·Granted Dec 1, 2009·15 cites·7 claims
- 0587US4879277AAntiviral compositions and methodsUS HEALTH·Filed 1987·Granted Nov 7, 1989·81 cites·17 claims
- 0685US6403568B14′-C-ethynyl pyrimidine nucleosides and pharmaceutical compositions thereofYAMASA CORP·Filed 2001·Granted Jun 11, 2002·21 cites·12 claims
- 0780US6333315B14′-C-ethynyl purine nucleoside compoundsYAMASA CORP·Filed 2000·Granted Dec 25, 2001·13 cites·12 claims
- 0879US9670225B2HIV-1 protease inhibitors and uses thereofPURDUE RESEARCH FOUNDATION·Filed 2015·Granted Jun 6, 2017·5 cites·20 claims
- 0978US8597876B2Method of treating HIV infectionERICKSON JOHN W·Filed 2007·Granted Dec 3, 2013·3 cites·57 claims
- 1077US6291670B14′-C-ethynyl pyrimidine nucleoside compounds and pharmaceutical compositionsYAMASA CORP·Filed 2000·Granted Sep 18, 2001·7 cites·8 claims
- 1176US4837311AAnti-retroviral compoundsHOFFMANN LA ROCHE·Filed 1987·Granted Jun 6, 1989·26 cites·41 claims
- 1274US9346820B2HIV-1 protease inhibitors having gem-di-fluoro bicyclic P2-ligandsPURDUE RESEARCH FOUNDATION·Filed 2014·Granted May 24, 2016·2 cites·15 claims
- 1371US11028096B2Tricyclic P2-ligand containing potent HIV-protease inhibitors against HIV/AIDSPURDUE RESEARCH FOUNDATION·Filed 2017·Granted Jun 8, 2021·1 cites·16 claims
- 1470US9024038B2Compunds and methods for treating HIVPURDUE RESEARCH FOUNDATION·Filed 2013·Granted May 5, 2015·1 cites·15 claims
- 1570US5565437A2',3'-dideoxy-2'-fluoro-purine nucleosides and methods for using sameUS HEALTH·Filed 1992·Granted Oct 15, 1996·22 cites·10 claims
- 1670US5376642ATreatment of retroviral induced dementia by administration of 2',3'-dideoxyinosineUS HEALTH·Filed 1993·Granted Dec 27, 1994·19 cites·1 claims
- 1767US7285552B2Drugs containing triazaspiro[5.5]undecane derivatives as the active ingredientONO PHARMACEUTICAL CO·Filed 2002·Granted Oct 23, 2007·3 cites·7 claims
- 1867US4935427APyrimidine and purine 1,2-butadiene-4-ols as anti-retroviral agentsUS HEALTH·Filed 1987·Granted Jun 19, 1990·8 cites·4 claims
- 1966US5459256ALipophilic, aminohydrolase-activated prodrugsUS HEALTH·Filed 1991·Granted Oct 17, 1995·24 cites·18 claims
- 2065US11390630B2Tricyclic P2-ligand containing potent HIV-protease inhibitors against HIV/AIDSPURDUE RESEARCH FOUNDATION·Filed 2021·Granted Jul 19, 2022·0 cites·15 claims
- 2164US11795159B2Compounds for the treatment of SARSPURDUE RESEARCH FOUNDATION·Filed 2022·Granted Oct 24, 2023·0 cites·9 claims
- 2264US8563597B2Fused tricyclic ether carbamates and their useGHOSH ARUN K·Filed 2011·Granted Oct 22, 2013·1 cites·20 claims
- 2359US9487541B2Fused tricyclic ether carbamates and their usePURDUE RESEARCH FOUNDATION·Filed 2013·Granted Nov 8, 2016·0 cites·20 claims
- 2458US9889115B2Fitness assay and associated methodsUS HEALTH·Filed 2013·Granted Feb 13, 2018·0 cites·6 claims
- 2558US7470506B1Fitness assay and associated methodsUS HEALTH·Filed 1999·Granted Dec 30, 2008·10 cites·9 claims
- 2658US2024043417A1Compounds for the treatment of sarsPURDUE RESEARCH FOUNDATION·Filed 2021·Application pending·0 cites
- 2757US5254539AMethod of treating HIV with 2',3'-dideoxyinosineUS HEALTH·Filed 1991·Granted Oct 19, 1993·17 cites·7 claims
- 2857US4704357AImmortalized T-lymphocyte cell line for testing HTLV-III inactivationUS HEALTH·Filed 1985·Granted Nov 3, 1987·16 cites·4 claims
- 2957US2024101541A1Compounds for the treatment of sarsPURDUE RESEARCH FOUNDATION·Filed 2021·Application pending·0 cites
- 3056US12454537B2HIV-1 protease inhibitors and uses thereofPURDUE RESEARCH FOUNDATION·Filed 2020·Granted Oct 28, 2025·0 cites·16 claims
- 3156US9808527B2Methods and compositions for treating HIV infectionsGHOSH ARUN K·Filed 2007·Granted Nov 7, 2017·0 cites·2 claims
- 3256US2005158713A1Fitness assay and associated methodsUNIV ILLINOIS·Filed 2005·Application pending·0 cites
- 3355US2023183207A1Compounds for the treatment of sarsPURDUE RESEARCH FOUNDATION·Filed 2021·Application pending·0 cites
- 3454US2023192671A1Compounds for the treatment of sarsPURDUE RESEARCH FOUNDATION·Filed 2021·Application pending·0 cites
- 3553US2022268786A1Method for assisting determination of exacerbation risk of covid-19NAT CENTER FOR GLOBAL HEALTH AND MEDICINE·Filed 2022·Application pending·0 cites
- 3652US2023159516A1Compounds for the treatment of sarsPURDUE RESEARCH FOUNDATION·Filed 2021·Application pending·0 cites
- 3751US5616566AMethod of inhibiting HIV replication with 2',3'-dideoxyadenosineUS HEALTH·Filed 1993·Granted Apr 1, 1997·12 cites·4 claims
- 3848US9499558B2Compounds and methods for treating HIVPURDUE RESEARCH FOUNDATION·Filed 2015·Granted Nov 22, 2016·0 cites·15 claims
- 3948US2023136594A1Tricyclic p2-ligand containing potent hiv-protease inhibitorsPURDUE RESEARCH FOUNDATION·Filed 2021·Application pending·0 cites
- 4042US11230550B2Macrocyclic HIV-1 protease inhibitors and uses thereofPURDUE RESEARCH FOUNDATION·Filed 2018·Granted Jan 25, 2022·0 cites·20 claims
- 4141US9309213B2C-3 substituted bicyclooctane based HIV protease inhibitorsGHOSH ARUN K·Filed 2012·Granted Apr 12, 2016·0 cites·17 claims
- 4240US10933067B2Nucleoside derivative having physiological activity such as antiviral activityNAT CENTER FOR GLOBAL HEALTH AND MEDICINE·Filed 2017·Granted Mar 2, 2021·0 cites·5 claims
- 4340US10472372B2HIV-1 protease inhibitors and uses thereofPURDUE RESEARCH FOUNDATION·Filed 2016·Granted Nov 12, 2019·0 cites·20 claims
- 4437US9062057B2CCR5 antagonists for treating HIVGHOSH ARUN K·Filed 2011·Granted Jun 23, 2015·0 cites·13 claims
- 4533US5580860APharmaceutical composition containing 2-amino-6-chloropurine-9-β-D-2',3'-dideoxyribofuranoxsideSANYO KOKUSAKU PULP CO·Filed 1989·Granted Dec 3, 1996·1 cites·1 claims
- 4630US5495010AAcid stable purine dideoxynucleosidesUS HEALTH·Filed 1991·Granted Feb 27, 1996·0 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when Hiroaki Mitsuya files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →